Guardant Health Inc
NASDAQ:GH
Guardant Health Inc
NASDAQ:GH
Price:
18.82 USD
-1.47%
Market Closed
Updated:
May 8, 2024
Guardant Health Inc
Cash from Operating Activities
|
Guardant Health Inc
Cash from Operating Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Guardant Health Inc
NASDAQ:GH
|
Cash from Operating Activities
-$325m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$1.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$10.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
19%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Guardant Health Inc's Cash from Operating Activities?
Cash from Operating Activities
-325m
USD
-325m
USD
Based on the financial report for Dec 31, 2023, Guardant Health Inc's Cash from Operating Activities amounts to -325m USD.
What is Guardant Health Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-35%
-35%
Over the last year, the Cash from Operating Activities growth was -5%. The average annual Cash from Operating Activities growth rates for Guardant Health Inc have been -46% over the past three years , -35% over the past five years .
You don't have any saved screeners yet
